SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-094624
Filing Date
2021-07-22
Accepted
2021-07-22 06:11:29
Documents
14
Period of Report
2021-07-21
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2122733d25_8k.htm   iXBRL 8-K 46650
2 EXHIBIT 3.1 tm2122733d25_ex3-1.htm EX-3.1 9228
3 EXHIBIT 3.2 tm2122733d25_ex3-2.htm EX-3.2 92210
  Complete submission text file 0001104659-21-094624.txt   347834

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alxn-20210721.xsd EX-101.SCH 3185
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxn-20210721_lab.xml EX-101.LAB 34593
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxn-20210721_pre.xml EX-101.PRE 22710
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2122733d25_8k_htm.xml XML 3613
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 211105927
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences